India Ratings has affirmed Chemfab Alkalis' credit rating at IND BBB+/Negative, citing a sluggish recovery in its OPVC pipe business. While the chlor-alkali segment shows improvement through modernization, the company faces stretched liquidity and increased leverage following debt-funded capex. Investors should monitor deleveraging efforts and the stability of operational margins amid these ongoing financial pressures.
Chemfab Alkalis Credit Rating Affirmed at IND BBB+ with Negative Outlook
Credit facilities totaling Rs 170 crore affirmed; net leverage increased to 4.0x in FY26.
Reader Takeaway: Chlor-alkali modernization offers stability, but weak pipe demand and stretched liquidity pressure the company’s outlook.
What just happened
India Ratings and Research (Ind-Ra) has affirmed the credit rating for Chemfab Alkalis Ltd (CAL) bank loan facilities at IND BBB+/Negative / IND A2. The rating action covers total facilities of Rs 170 crore. The 'Negative' outlook reflects concerns over the company's financial profile following slower-than-anticipated recovery in operations through FY26 and the first quarter of FY27.
Why this matters
The company has struggled with the OPVC pipe business due to lower demand under the Jal Jeevan Mission, leading to significant capacity underutilization. While the chlor-alkali segment has benefited from modernization and improved pricing, the overall financial health has been impacted by rising debt levels and tightening liquidity. Net leverage rose to 4.0x in FY26 compared to 1.4x in FY25, while gross interest coverage declined to 3.5x from 8.9x.
Operational Updates
Chemfab Alkalis is attempting to diversify its pipe business by targeting non-JJM government and private sector projects, holding an order book of Rs 17 crore as of September 2026. On the cost front, the commissioning of a hybrid power project in May 2026 is projected to save Rs 15 crore annually. Further operational optimizations targeted for completion by October 2026 are expected to provide an additional Rs 5-6 crore in annual savings.
Risks to watch
Execution risk remains high, particularly regarding the recovery of the pipe segment. Stretched liquidity remains a primary concern; the company's cash and liquid investments dropped to approximately Rs 1 crore by the end of 1QFY27. Future credit stability is contingent on successful deleveraging and the ability to maintain adequate liquidity buffers, including support from associate entities.
What to track next
Investors should monitor the company's ability to reduce debt through operational cash flow and the effectiveness of the recent capex initiatives. Sustained margin improvement in the chlor-alkali segment and the successful diversification of the pipe order book are critical milestones for a potential outlook revision.